Victoria Clinical Research Group | Victoria, TX

Research site
2700 Citizens Plaza Suite 206, Victoria, Texas, United States of America
Site insights

Top conditions

Epstein-Barr Virus Infections (1 trial)

Virus Diseases (1 trial)

Migraine Disorders (1 trial)

Top treatments


Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


4 of 4
Status: Active
Trial type: Interventional
Funder type: Industry

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 12- to 30-Year-Old Healthy Adolescents and Adults

The main objective of Part A of this trial is to evaluate the safety and reactogenicity of mRNA-1189 in 18- to 30-year-old healthy adults and the mai...

Active, not recruiting
Epstein-Barr Virus Infection
Biological: mRNA-1189
Biological: Placebo

The purpose of the study is to evaluate the safety, reactogenicity, and immunogenicity of mRNA-1345 in children aged 2 to <5 years of age and in chil...

Active, not recruiting
Respiratory Syncytial Virus
Biological: mRNA-1345
Biological: Placebo

This study will evaluate the safety and immunogenicity of the mRNA-1273.214 vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...

Biological: mRNA-1273.214
Biological: mRNA-1273.815

The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and ado...

Drug: Placebo
Drug: Rimegepant

Trial sponsors

Moderna logo

Moderna (3 trials)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems